Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000705442 | SCV000834439 | likely benign | Episodic ataxia type 2; Developmental and epileptic encephalopathy, 42 | 2023-12-07 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001091781 | SCV001247991 | uncertain significance | not provided | 2019-10-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001091781 | SCV001991471 | uncertain significance | not provided | 2019-08-01 | criteria provided, single submitter | clinical testing | Not observed at a significant frequency in large population cohorts (Lek et al., 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Has not been previously published as pathogenic or benign to our knowledge |
Prevention |
RCV003985413 | SCV004709441 | likely benign | CACNA1A-related disorder | 2023-03-27 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |